Anson Funds Management LP
- SEC CIK
- 0001491072
- Latest filing
- Aug 13, 2026
NRXP holding history
NRX Pharmaceuticals, Inc. in every 13F filed by Anson Funds Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NRXP overviewAll 13F holders of NRXPFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −3,043,957−100.0% | Sold out | Holders |
| Q4 2025 | 3,043,957 | $8.25M | 1.1% | +1,018,853+50.3% | Added | Holders |
| Q3 2025 | 2,025,104 | $6.68M | 0.7% | +420,129+26.2% | Added | Holders |
| Q2 2025 | 1,604,975 | $5.23M | 1.0% | +425,914+36.1% | Added | Holders |
| Q1 2025 | 1,179,061 | $2.42M | 0.6% | +993,401+535.1% | Added | Holders |
| Q4 2024 | 185,660 | $408.5K | 0.1% | +43,135+30.3% | Added | Holders |
| Q3 2024 | 142,525 | $240.9K | <0.1% | +142,525 | New | Holders |